Logo
x

Search

Subscribe Now

20 Years

Galderma's Aklief (trifarotene) Receives the US FDA's Approval for the Treatment of Acne in 20 Years

Galderma's Aklief (trifarotene) Receives the US FDA's Approval for the Treatment of Acne in 20 Years

  • October 4, 2019
Bristol-Myers's Opdivo (nivolumab) Receives FDA Priority Review for 2L+ Patients with SCLC in ~20 yrs

Bristol-Myers's Opdivo (nivolumab) Receives FDA Priority Review for 2L+ Patients with SCLC in ~20 yrs

  • August 17, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.